Blood Clotting Factor VIII: From Evolution to Therapy
作者： N. A. Orlova , S. V. Kovnir , I. I. Vorobiev , A. G. Gabibov , A. I. Vorobiev
DOI: 10.32607/20758251-2013-5-2-19-39
关键词:
摘要: … by the fact that liver transplantation can cure hemophilia A. When … binding of FVIII to the membranes of vascular endothelial … anti-factor VIII antibodies can specifically hydrolyze FVIII [96], …
scienceopen.com
sci-hub.st 参考文章(181)
Thomas Abshire, Cassandra D Josephson, The new albumin-free recombinant factor VIII concentrates for treatment of hemophilia: do they represent an actual incremental improvement? Clinical advances in hematology & oncology. ,vol. 2, pp. 441- ,(2004)
P.J. Lenting, M.J. Donath, J.A. van Mourik, K. Mertens, Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII. Journal of Biological Chemistry. ,vol. 269, pp. 7150- 7155 ,(1994) , 10.1016/S0021-9258(17)37260-5
Shouichi Yokozaki, Yoshihide Fukuda, Isao Nakano, Yoshiaki Katano, Hidenori Toyoda, Junki Takamatsu, Detection of TT virus DNA in plasma-derived clotting factor concentrates. Blood. ,vol. 94, pp. 3617- 3617 ,(1999) , 10.1182/BLOOD.V94.10.3617.422A38F_3617_3617
Marianne Kjalke, Anders Heding, Gert Talbo, Egon Persson, Johannes Thomsen, Mirella Ezban, Amino Acid Residues 721–729 are Required for Full Factor VIII Activity FEBS Journal. ,vol. 234, pp. 773- 779 ,(1995) , 10.1111/J.1432-1033.1995.773_A.X
Hironao Wakabayashi, Kyla M. Schmidt, Philip J. Fay, Ca2+ Binding to Both the Heavy and Light Chains of Factor VIII Is Required for Cofactor Activity† Biochemistry. ,vol. 41, pp. 8485- 8492 ,(2002) , 10.1021/BI025589O
C. K. Mukhopadhyay, B. Mazumder, P. F. Lindley, P. L. Fox, Identification of the prooxidant site of human ceruloplasmin: A model for oxidative damage by copper bound to protein surfaces Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 11546- 11551 ,(1997) , 10.1073/PNAS.94.21.11546
Pete Lollar, Gaylord J. Knutson, David N. Fass, Activation of porcine factor VIII:C by thrombin and factor Xa. Biochemistry. ,vol. 24, pp. 8056- 8064 ,(1985) , 10.1021/BI00348A033
J. D. Johnson, J. C. Edman, W. J. Rutter, A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 5677- 5681 ,(1993) , 10.1073/PNAS.90.12.5677
Vincenzo Toschi, OBI-1, porcine recombinant Factor VIII for the potential treatment of patients with congenital hemophilia A and alloantibodies against human Factor VIII. Current Opinion in Molecular Therapeutics. ,vol. 12, pp. 617- 625 ,(2010)
A Leyte, M P Verbeet, T Brodniewicz-Proba, J A Van Mourik, K Mertens, The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. Biochemical Journal. ,vol. 257, pp. 679- 683 ,(1989) , 10.1042/BJ2570679